首页 > 最新文献

Colombia Medica最新文献

英文 中文
Edición de genes para el tratamiento del cáncer de pulmón (CRISPR-Cas9). 肺癌治疗的基因编辑(CRISPR-Cas9)。
IF 1.1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2016-12-29 DOI: 10.25100/CM.V47I4.2856
A. Castillo
In 2015, the journal Science chose CRISPR-Cas9 technology as the most important technological advance of science in the last years1. This magazine announced the beginning of a new era of biotechnology in which it would be possible to edit, correct and modify the genetic information of any cell in a feasible, fast and cheap way; and most importantly, with high precision. Its implementation in research laboratories in basic and applied sciences could help to develop therapeutic strategies for the health area with the main objective of healing diseases with a known genetic origin, and that until now have been impossible to cure.
2015年,《科学》杂志将CRISPR-Cas9技术评为近年来最重要的科学技术进步1。这本杂志宣布了一个生物技术新时代的开始,在这个时代,以一种可行、快速和廉价的方式编辑、纠正和修改任何细胞的遗传信息将成为可能;最重要的是,精度高。在基础科学和应用科学的研究实验室中实施这一方案可以帮助制定保健领域的治疗战略,其主要目标是治疗具有已知遗传起源的疾病,这些疾病迄今无法治愈。
{"title":"Edición de genes para el tratamiento del cáncer de pulmón (CRISPR-Cas9).","authors":"A. Castillo","doi":"10.25100/CM.V47I4.2856","DOIUrl":"https://doi.org/10.25100/CM.V47I4.2856","url":null,"abstract":"In 2015, the journal Science chose CRISPR-Cas9 technology as the most important technological advance of science in the last years1. This magazine announced the beginning of a new era of biotechnology in which it would be possible to edit, correct and modify the genetic information of any cell in a feasible, fast and cheap way; and most importantly, with high precision. Its implementation in research laboratories in basic and applied sciences could help to develop therapeutic strategies for the health area with the main objective of healing diseases with a known genetic origin, and that until now have been impossible to cure.","PeriodicalId":50667,"journal":{"name":"Colombia Medica","volume":"54 1","pages":"178-180"},"PeriodicalIF":1.1,"publicationDate":"2016-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75276173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Polimorfismos en el gen lipoproteína lipasa como marcadores genéticos para enfermedad cerebrovascular en la población colombiana: estudio de casos y controles 作为哥伦比亚人群脑血管疾病遗传标记的脂蛋白脂肪酶基因多态性:病例和对照研究
IF 1.1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2016-12-21 DOI: 10.25100/CM.V47I4.1683
Leydi Carolina Velásquez Pereira, Clara Inés Vargas Castellanos, F. A. S. Sieger
Objective:To analyze if there is an association between the presence of polymorphisms in the LPL gene (rs320, rs285 and rs328) with development of acute ischemic stroke in Colombian population.Methods:In a case control design, 133 acute ischemic stroke patients (clinical diagnosis and x-ray CT) and 269 subjects without stroke as controls were studied. PCR -RFLP technique was used to detect rs320, rs285 and rs328 polymorphisms in the LPL gene.Results:In the present research was not found any association between any of the LPL gene polymorphism and acute ischemic stroke in the population studied; the allele and genotypic frequencies of the studied polymorphisms were similar in cases and controls and followed the Hardy-Weinberg equilibrium. The study was approved by the IRB and each subject signed the informed consent.Conclusion:LPL gene polymorphisms are not genetic markers for the development of stroke in the Colombian sample used.
目的:分析哥伦比亚人群LPL基因(rs320、rs285和rs328)多态性的存在与急性缺血性卒中的发生是否存在关联。方法:采用病例对照设计,选取133例急性缺血性脑卒中患者(临床诊断及x线CT)和269例非脑卒中患者作为对照。采用PCR -RFLP技术检测LPL基因rs320、rs285和rs328多态性。结果:在本研究中未发现LPL基因多态性与研究人群急性缺血性脑卒中之间的任何关联;研究的多态性的等位基因和基因型频率在病例和对照中相似,并遵循Hardy-Weinberg平衡。本研究经IRB批准,每位受试者都签署了知情同意书。结论:LPL基因多态性不是哥伦比亚样本中卒中发展的遗传标记。
{"title":"Polimorfismos en el gen lipoproteína lipasa como marcadores genéticos para enfermedad cerebrovascular en la población colombiana: estudio de casos y controles","authors":"Leydi Carolina Velásquez Pereira, Clara Inés Vargas Castellanos, F. A. S. Sieger","doi":"10.25100/CM.V47I4.1683","DOIUrl":"https://doi.org/10.25100/CM.V47I4.1683","url":null,"abstract":"Objective:To analyze if there is an association between the presence of polymorphisms in the LPL gene (rs320, rs285 and rs328) with development of acute ischemic stroke in Colombian population.Methods:In a case control design, 133 acute ischemic stroke patients (clinical diagnosis and x-ray CT) and 269 subjects without stroke as controls were studied. PCR -RFLP technique was used to detect rs320, rs285 and rs328 polymorphisms in the LPL gene.Results:In the present research was not found any association between any of the LPL gene polymorphism and acute ischemic stroke in the population studied; the allele and genotypic frequencies of the studied polymorphisms were similar in cases and controls and followed the Hardy-Weinberg equilibrium. The study was approved by the IRB and each subject signed the informed consent.Conclusion:LPL gene polymorphisms are not genetic markers for the development of stroke in the Colombian sample used.","PeriodicalId":50667,"journal":{"name":"Colombia Medica","volume":"16 1","pages":"189-195"},"PeriodicalIF":1.1,"publicationDate":"2016-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74665872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Vitamin D (25(OH)D) in patients with chronic kidney disease stages 2-5. 维生素D(25(OH)D)在2-5期慢性肾脏疾病患者中的应用。
IF 1.1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2016-09-30
César Augusto Restrepo Valencia, José Vicente Aguirre Arango
<p><strong>Objective: </strong>To establish the impact the chronic kidney disease stage has in the native vitamin D levels in patients not undergoing dialysis treatment.</p><p><strong>Methods: </strong>A study performed in Manizales, Colombia, a city located 2,200 meters above sea level, without important stational variations. Patients with 18 years of age or more, with chronic kidney disease stages 2 to 5 and not undergoing dialysis treatment were recruited for this study. Demographic and anthropometric variations were evaluated as well as solar exposure, CKD etiology and laboratory variables related to bone and mineral diseases. For each CKD clinical stage, correlations were evaluated for vitamin D levels, laboratory results for bone and mineral diseases, solar exposure and ethnicity.</p><p><strong>Results: </strong>Three hundred thirty-three patients were evaluated with a median age of 71 years, most of them mestizo (71%), 173 were women. The main CKD etiology was hypertensive nephropathy (32.2%). 21.1% of patients had normal vitamin D levels, 70.1% were within insufficient range and 8.8% were in deficit. A negative correlation was found between the levels of vitamin 25 (OH) D and the values for: creatinine, phosphorous, calcium x phosphorous product, PTH, 24 hours urine protein and BMI. A positive relationship was found for calcium and albumin. Positive significant statistical correlation was found for vitamin 25(OH) D levels and solar exposure for stages 3b and 4 of CKD.</p><p><strong>Conclusions: </strong>It is common to find low levels of vitamin 25(OH) D in patients with CKD; these can contribute to the appearance of secondary hyperparathyroidism.</p><p><strong>Objetivo: </strong>Establecer el impacto del estadio clínico en los niveles de vitamina D nativa en pacientes con enfermedad renal crónica (ERC) sin diálisis.</p><p><strong>Métodos: </strong>Estudio realizado en Manizales, Colombia, una ciudad tropical ubicada a 2,200 metros de altura sobre el nivel del mar, sin variaciones estacionales importantes a lo largo del año. Se incluyeron pacientes mayores de 18 años, con enfermedad renal crónica estadio 2 a 5 sin tratamiento dialítico. En ellos se evaluaron variables demográficas, antropométricas, grado de exposición solar, etiología de la enfermedad, y variables de laboratorio relacionadas con desórdenes óseos y minerales. Para cada estadío clínico se evaluó la correlación entre los niveles de vitamina D y los resultados de las pruebas de laboratorio relacionadas con desordenes óseos y minerales, exposición solar y etnia.</p><p><strong>Resultados: </strong>Se evaluaron 331 pacientes, con una edad media de 71 años, la mayoría mestizos (71%), 173 mujeres. La principal etiología de ERC fue nefropatía hipertensiva (33.2%). El 21.1% de los pacientes tenían niveles normales de vitamina D, fueron insuficientes en 70.1% y 8.8% en déficit. Se detectó correlación negativa, entre los niveles de vitamina 25(OH)D y los valores de creatinina, fósforo
目的:确定慢性肾脏疾病阶段对未接受透析治疗的患者天然维生素D水平的影响。方法:在哥伦比亚马尼萨雷斯进行的一项研究,这是一个位于海平面以上2200米的城市,没有重大的统计变化。招募了18岁或18岁以上患有2至5期慢性肾脏疾病且未接受透析治疗的患者进行这项研究。评估了人口和人类测量的变化,以及与骨骼和矿物疾病有关的太阳照射、CKD病因和实验室变量。对于每个CKD临床阶段,评估了维生素D水平、骨骼和矿物质疾病实验室结果、阳光照射和种族的相关性。结果:333名患者接受了评估,平均年龄为71岁,其中大多数是混血儿(71%),173人为女性。CKD的主要病因为高血压肾病(32.2%)。21.1%的患者维生素D水平正常,70.1%的患者维生素D水平不足,8.8%的患者维生素D水平不足。维生素25(OH)D水平与肌酐、磷、钙x磷产品、PTH、24小时尿蛋白和BMI的值呈负相关。钙和白蛋白呈阳性关系。CKD第3b和第4阶段的维生素25(OH)d水平与太阳照射呈正相关。结论:CKD患者维生素25(OH)d水平较低是很常见的;这些可能有助于继发性甲状旁腺功能亢进的出现。目的:确定临床阶段对未透析的慢性肾脏病患者天然维生素D水平的影响。方法:在哥伦比亚马尼萨雷斯进行的一项研究,这是一个海拔2200米的热带城市,全年没有明显的季节变化。包括18岁以上未经透析治疗的2至5期慢性肾脏疾病患者。他们评估了人口统计、人体测量、阳光照射程度、疾病病因以及与骨和矿物质疾病有关的实验室变量。对于每个临床分期,评估了维生素D水平与与骨和矿物质障碍、阳光照射和种族相关的实验室测试结果之间的相关性。结果:评估了331名患者,平均年龄为71岁,主要是混血儿(71%),173名女性。CKD的主要病因是高血压肾病(33.2%)。21.1%的患者维生素D水平正常,70.1%的患者维生素D水平不足,8.8%的患者维生素D水平不足。维生素25(OH)D水平与肌酐、磷、产物钙x磷、PTH、24小时尿蛋白和BMI值呈负相关。钙和白蛋白呈正相关。在第3b和第4阶段,维生素25(OH)d水平与阳光照射之间发现了积极的统计意义。结论:在慢性肾脏病患者中,经常发现25(OH)d水平较低,这可能导致继发性甲状旁腺功能亢进的发生。
{"title":"Vitamin D (25(OH)D) in patients with chronic kidney disease stages 2-5.","authors":"César Augusto Restrepo Valencia, José Vicente Aguirre Arango","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To establish the impact the chronic kidney disease stage has in the native vitamin D levels in patients not undergoing dialysis treatment.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A study performed in Manizales, Colombia, a city located 2,200 meters above sea level, without important stational variations. Patients with 18 years of age or more, with chronic kidney disease stages 2 to 5 and not undergoing dialysis treatment were recruited for this study. Demographic and anthropometric variations were evaluated as well as solar exposure, CKD etiology and laboratory variables related to bone and mineral diseases. For each CKD clinical stage, correlations were evaluated for vitamin D levels, laboratory results for bone and mineral diseases, solar exposure and ethnicity.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Three hundred thirty-three patients were evaluated with a median age of 71 years, most of them mestizo (71%), 173 were women. The main CKD etiology was hypertensive nephropathy (32.2%). 21.1% of patients had normal vitamin D levels, 70.1% were within insufficient range and 8.8% were in deficit. A negative correlation was found between the levels of vitamin 25 (OH) D and the values for: creatinine, phosphorous, calcium x phosphorous product, PTH, 24 hours urine protein and BMI. A positive relationship was found for calcium and albumin. Positive significant statistical correlation was found for vitamin 25(OH) D levels and solar exposure for stages 3b and 4 of CKD.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusions: &lt;/strong&gt;It is common to find low levels of vitamin 25(OH) D in patients with CKD; these can contribute to the appearance of secondary hyperparathyroidism.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Objetivo: &lt;/strong&gt;Establecer el impacto del estadio clínico en los niveles de vitamina D nativa en pacientes con enfermedad renal crónica (ERC) sin diálisis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Métodos: &lt;/strong&gt;Estudio realizado en Manizales, Colombia, una ciudad tropical ubicada a 2,200 metros de altura sobre el nivel del mar, sin variaciones estacionales importantes a lo largo del año. Se incluyeron pacientes mayores de 18 años, con enfermedad renal crónica estadio 2 a 5 sin tratamiento dialítico. En ellos se evaluaron variables demográficas, antropométricas, grado de exposición solar, etiología de la enfermedad, y variables de laboratorio relacionadas con desórdenes óseos y minerales. Para cada estadío clínico se evaluó la correlación entre los niveles de vitamina D y los resultados de las pruebas de laboratorio relacionadas con desordenes óseos y minerales, exposición solar y etnia.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Resultados: &lt;/strong&gt;Se evaluaron 331 pacientes, con una edad media de 71 años, la mayoría mestizos (71%), 173 mujeres. La principal etiología de ERC fue nefropatía hipertensiva (33.2%). El 21.1% de los pacientes tenían niveles normales de vitamina D, fueron insuficientes en 70.1% y 8.8% en déficit. Se detectó correlación negativa, entre los niveles de vitamina 25(OH)D y los valores de creatinina, fósforo","PeriodicalId":50667,"journal":{"name":"Colombia Medica","volume":"47 3","pages":"160-166"},"PeriodicalIF":1.1,"publicationDate":"2016-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091275/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72211759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Guía de práctica clínica para la prevención, diagnóstico, tratamiento y seguimiento de la diabetes mellitus tipo 2 en la población mayor de 18 años 预防、诊断、治疗和监测18岁以上人群2型糖尿病的临床实践指南
IF 1.1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2016-06-24 DOI: 10.25100/CM.V47I2.2207
P. Aschner, Oscar Mauricio Muñoz, D. Girón, Olga Milena García, D. F. Fernández Ávila, Luz Ángela Casas, Luisa Fernanda Bohorquez, Clara María Arángo T., L. Carvajal, Doris Amanda Ramírez, J. G. Sarmiento, Cristian Alejandro Colón, Nestor Fabián Correa G., Pilar Alarcón R., Alvaro Andrés Bústamante S.
In Colombia, diabetes mellitus is a public health program for those responsible for creating and implementing strategies for prevention, diagnosis, treatment, and follow-up that are applicable at all care levels, with the objective of establishing early and sustained control of diabetes. A clinical practice guide has been developed following the broad outline of the methodological guide from the Ministry of Health and Social Welfare, with the aim of systematically gathering scientific evidence and formulating recommendations using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) methodology. The current document presents in summary form the results of this process, including the recommendations and the considerations taken into account in formulating them. In general terms, what is proposed here is a screening process using the Finnish Diabetes Risk Score questionnaire adapted to the Colombian population, which enables early diagnosis of the illness, and an algorithm for determining initial treatment that can be generalized to most patients with diabetes mellitus type 2 and that is simple to apply in a primary care context. In addition, several recommendations have been made to scale up pharmacological treatment in those patients that do not achieve the objectives or fail to maintain them during initial treatment. These recommendations also take into account the evolution of weight and the individualization of glycemic control goals for special populations. Finally, recommendations have been made for opportune detection of micro- and macrovascular complications of diabetes.
在哥伦比亚,糖尿病是一项公共卫生方案,由负责制定和实施适用于所有护理级别的预防、诊断、治疗和后续行动战略的人员执行,其目标是建立对糖尿病的早期和持续控制。根据卫生和社会福利部方法学指南的大致大纲,制定了一份临床实践指南,目的是系统地收集科学证据,并使用GRADE(建议评估、发展和评价分级)方法制定建议。本文件以摘要形式介绍这一进程的结果,包括各项建议和在拟订这些建议时所考虑的因素。总的来说,这里提出的是一种筛选过程,使用适用于哥伦比亚人口的芬兰糖尿病风险评分问卷,这可以早期诊断疾病,并确定一种可以推广到大多数2型糖尿病患者的初始治疗算法,并且可以简单地应用于初级保健环境。此外,已经提出了一些建议,以扩大对那些没有达到目标或在初始治疗期间未能维持目标的患者的药物治疗。这些建议还考虑到体重的变化和特殊人群血糖控制目标的个体化。最后,对糖尿病的微血管和大血管并发症的及时检测提出了建议。
{"title":"Guía de práctica clínica para la prevención, diagnóstico, tratamiento y seguimiento de la diabetes mellitus tipo 2 en la población mayor de 18 años","authors":"P. Aschner, Oscar Mauricio Muñoz, D. Girón, Olga Milena García, D. F. Fernández Ávila, Luz Ángela Casas, Luisa Fernanda Bohorquez, Clara María Arángo T., L. Carvajal, Doris Amanda Ramírez, J. G. Sarmiento, Cristian Alejandro Colón, Nestor Fabián Correa G., Pilar Alarcón R., Alvaro Andrés Bústamante S.","doi":"10.25100/CM.V47I2.2207","DOIUrl":"https://doi.org/10.25100/CM.V47I2.2207","url":null,"abstract":"In Colombia, diabetes mellitus is a public health program for those \u0000responsible for creating and implementing strategies for prevention, \u0000diagnosis, treatment, and follow-up that are applicable at all care \u0000levels, with the objective of establishing early and sustained control \u0000of diabetes. A clinical practice guide has been developed following \u0000the broad outline of the methodological guide from the Ministry \u0000of Health and Social Welfare, with the aim of systematically \u0000gathering scientific evidence and formulating recommendations \u0000using the GRADE (Grading of Recommendations Assessment, \u0000Development and Evaluation) methodology. The current document \u0000presents in summary form the results of this process, including the \u0000recommendations and the considerations taken into account in \u0000formulating them. \u0000In general terms, what is proposed here is a screening process using the \u0000Finnish Diabetes Risk Score questionnaire adapted to the Colombian \u0000population, which enables early diagnosis of the illness, and an \u0000algorithm for determining initial treatment that can be generalized to \u0000most patients with diabetes mellitus type 2 and that is simple to apply \u0000in a primary care context. In addition, several recommendations \u0000have been made to scale up pharmacological treatment in those \u0000patients that do not achieve the objectives or fail to maintain them \u0000during initial treatment. These recommendations also take into \u0000account the evolution of weight and the individualization of glycemic \u0000control goals for special populations. Finally, recommendations have \u0000been made for opportune detection of micro- and macrovascular \u0000complications of diabetes.","PeriodicalId":50667,"journal":{"name":"Colombia Medica","volume":"37 1","pages":"109-130"},"PeriodicalIF":1.1,"publicationDate":"2016-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73671818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 35
Evaluación de la diásquisis transcallosa en un modelo murino de isquemia cerebral focal 局灶性脑缺血小鼠模型经胼胝体透析的评价
IF 1.1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2016-06-13 DOI: 10.25100/CM.V47I2.2146
C. Arango-Dávila, B. Muñoz, D. M. Castaño, Laura Potes, John Umbarila
{"title":"Evaluación de la diásquisis transcallosa en un modelo murino de isquemia cerebral focal","authors":"C. Arango-Dávila, B. Muñoz, D. M. Castaño, Laura Potes, John Umbarila","doi":"10.25100/CM.V47I2.2146","DOIUrl":"https://doi.org/10.25100/CM.V47I2.2146","url":null,"abstract":"","PeriodicalId":50667,"journal":{"name":"Colombia Medica","volume":"32 1","pages":"87-93"},"PeriodicalIF":1.1,"publicationDate":"2016-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82669901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Frecuencia de linfocitosis monoclonal de células B en familiares de pacientes con leucemia linfoide crónica
IF 1.1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2016-06-08 DOI: 10.25100/CM.V47I2.1879
Rossana Villegas Gracia, Catalina Franco Alzate, Javier Rendón Henao, José Domingo Torres Hernández, P. Arbelaez
{"title":"Frecuencia de linfocitosis monoclonal de células B en familiares de pacientes con leucemia linfoide crónica","authors":"Rossana Villegas Gracia, Catalina Franco Alzate, Javier Rendón Henao, José Domingo Torres Hernández, P. Arbelaez","doi":"10.25100/CM.V47I2.1879","DOIUrl":"https://doi.org/10.25100/CM.V47I2.1879","url":null,"abstract":"","PeriodicalId":50667,"journal":{"name":"Colombia Medica","volume":"11 1","pages":"81-86"},"PeriodicalIF":1.1,"publicationDate":"2016-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78809709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Evocación al Dr. Carlos J. Finlay Barrés en el centenario de su fallecimiento 卡洛斯·j·芬利博士逝世一百周年纪念barres
IF 1.1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2016-02-19 DOI: 10.25100/CM.V47I1.2019
V. Moreno
About the editorial of the Professor Guillermo Llanos: "Carlos J. Finlay: the forgotten Pasteur of America", a hundred years after his death and through a documental review, a summary of the life and work of this great man of science was conducted. Finlay was a notable figure of the American medicine, he conceived a new infection way able to explain the propagation of the yellow fever, and added the possibility of their scientific confirmation by an experimental method. For all the above-mentioned Finlay was recognized as the humanity's benefactor Article history:
关于Guillermo Llanos教授的社论:“Carlos J. Finlay:被遗忘的美国巴斯德”,在他去世一百年后,通过文献回顾,对这位伟大的科学人物的生活和工作进行了总结。芬利是美国医学界的一位著名人物,他提出了一种新的感染方式,能够解释黄热病的传播,并增加了通过实验方法科学证实的可能性。对于上述所有芬利被认为是人类的恩人文章历史:
{"title":"Evocación al Dr. Carlos J. Finlay Barrés en el centenario de su fallecimiento","authors":"V. Moreno","doi":"10.25100/CM.V47I1.2019","DOIUrl":"https://doi.org/10.25100/CM.V47I1.2019","url":null,"abstract":"About the editorial of the Professor Guillermo Llanos: \"Carlos J. Finlay: the forgotten Pasteur of America\", a hundred years after his death and through a documental review, a summary of the life and work of this great man of science was conducted. Finlay was a notable figure of the American medicine, he conceived a new infection way able to explain the propagation of the yellow fever, and added the possibility of their scientific confirmation by an experimental method. For all the above-mentioned Finlay was recognized as the humanity's benefactor Article history:","PeriodicalId":50667,"journal":{"name":"Colombia Medica","volume":"1 1","pages":"63-66"},"PeriodicalIF":1.1,"publicationDate":"2016-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84350195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Las visitas de equipos de cuidados paliativos: Estudio cualitativo mediante observación participante 姑息治疗团队访问:参与观察的定性研究
IF 1.1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2016-02-19 DOI: 10.25100/CM.V47I1.2022
María del Mar Alfaya Góngora, Mª José Bueno Pernias, C. H. Montoro, P. G. Mancilla, R. Juárez, M. P. G. Caro
{"title":"Las visitas de equipos de cuidados paliativos: Estudio cualitativo mediante observación participante","authors":"María del Mar Alfaya Góngora, Mª José Bueno Pernias, C. H. Montoro, P. G. Mancilla, R. Juárez, M. P. G. Caro","doi":"10.25100/CM.V47I1.2022","DOIUrl":"https://doi.org/10.25100/CM.V47I1.2022","url":null,"abstract":"","PeriodicalId":50667,"journal":{"name":"Colombia Medica","volume":"2016 1","pages":"38-44"},"PeriodicalIF":1.1,"publicationDate":"2016-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73403128","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Self-reported vaccination in the elderly: SABE study Bogotá, Colombia 老年人自我报告的疫苗接种:哥伦比亚波哥大<e:1>的SABE研究
IF 1.1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2016-02-19 DOI: 10.25100/CM.V47I1.2107
C. Cano, C. Reyes-Ortiz, Miguel Germán Borda, Antonio J. Arciniegas
Objetivos: determinar la frecuencia de vacunacion en la poblacion adulta mayor de la ciudad de Bogota, y estimar la asociacion con factores sociodemograficos y de salud.Metodos: Este es un analisis secundario de datos del estudio SABE-Bogota, un estudio poblacional transversal que incluyo un total de 2,000 personas mayores de 60 anos. Se obtuvieron porcentajes ponderados del auto-reporte de vacunacion (influenza, neumococo, tetano). La asociacion entre la vacunacion y otras variables se evaluo mediante modelos de regresion logistica.Resultados: el 73.0% se vacuno contra la Influenza, 57.8% contra el Neumococo y el 47.6% recibio la antitetanica. Los factores que estaba independientemente asociados con la vacunacion incluyen: 1-edad (65-74 tenian probabilidad aumentada comparada con 60-64 anos); 2- nivel socioeconomico (NSE) (mayor NSE tenian menos probabilidades de tener vacunas contra la influenza y neumococo, en comparacion con aquellos con menor SES); 3- seguro de salud (con seguro contributivo o subsidiado tenian probabilidades mas altas, (entre 3 y 5 veces mayor) de tener vacunacion contra la influenza, neumococo y tetanos, en comparacion con aquellos que no tienen seguro); 4- aquellos con estado funcional mejor (puntaje mayor Lawton) tenian probabilidades mayores para todas las vacunas; 5- aquellos con morbilidad aumentada tenian probabilidades mayores para tener vacunas de influenza y neumococo.Conclusion: Las campanas de vacunacion se deben fortalecer para incrementan la cobertura, especialmente en el grupo mas reacio a la vacunacion o vulnerable para alcanzarla tales como los adultos mayores con discapacidad.
目的:确定波哥大市老年人接种疫苗的频率,并评估其与社会人口学和健康因素的关系。方法:这是对SABE-Bogota研究数据的二次分析,这是一项横断面人口研究,共包括2000名60岁以上的人。获得自我报告疫苗接种(流感、肺炎球菌、破伤风)的加权百分比。使用logistic回归模型评估疫苗接种与其他变量之间的关联。结果:73.0%的人接种流感疫苗,57.8%的人接种肺炎球菌疫苗,47.6%的人接种破伤风疫苗。与疫苗接种独立相关的因素包括:1岁(与60-64岁相比,65-74岁的可能性增加);2-社会经济水平(sss)(与sss较低的人相比,sss较高的人不太可能接种流感和肺炎球菌疫苗);3-健康保险(与没有保险的人相比,有缴费或补贴保险的人接种流感、肺炎球菌和破伤风疫苗的几率更高(3至5倍));4-功能状态较好的人(劳顿评分较高)接种所有疫苗的几率更高;5-发病率增加的人更有可能接种流感和肺炎球菌疫苗。结论:应加强疫苗接种运动,以增加覆盖率,特别是在最不愿接种疫苗或易受疫苗接种影响的群体,如残疾老年人。
{"title":"Self-reported vaccination in the elderly: SABE study Bogotá, Colombia","authors":"C. Cano, C. Reyes-Ortiz, Miguel Germán Borda, Antonio J. Arciniegas","doi":"10.25100/CM.V47I1.2107","DOIUrl":"https://doi.org/10.25100/CM.V47I1.2107","url":null,"abstract":"Objetivos: determinar la frecuencia de vacunacion en la poblacion adulta mayor de la ciudad de Bogota, y estimar la asociacion con factores sociodemograficos y de salud.Metodos: Este es un analisis secundario de datos del estudio SABE-Bogota, un estudio poblacional transversal que incluyo un total de 2,000 personas mayores de 60 anos. Se obtuvieron porcentajes ponderados del auto-reporte de vacunacion (influenza, neumococo, tetano). La asociacion entre la vacunacion y otras variables se evaluo mediante modelos de regresion logistica.Resultados: el 73.0% se vacuno contra la Influenza, 57.8% contra el Neumococo y el 47.6% recibio la antitetanica. Los factores que estaba independientemente asociados con la vacunacion incluyen: 1-edad (65-74 tenian probabilidad aumentada comparada con 60-64 anos); 2- nivel socioeconomico (NSE) (mayor NSE tenian menos probabilidades de tener vacunas contra la influenza y neumococo, en comparacion con aquellos con menor SES); 3- seguro de salud (con seguro contributivo o subsidiado tenian probabilidades mas altas, (entre 3 y 5 veces mayor) de tener vacunacion contra la influenza, neumococo y tetanos, en comparacion con aquellos que no tienen seguro); 4- aquellos con estado funcional mejor (puntaje mayor Lawton) tenian probabilidades mayores para todas las vacunas; 5- aquellos con morbilidad aumentada tenian probabilidades mayores para tener vacunas de influenza y neumococo.Conclusion: Las campanas de vacunacion se deben fortalecer para incrementan la cobertura, especialmente en el grupo mas reacio a la vacunacion o vulnerable para alcanzarla tales como los adultos mayores con discapacidad.","PeriodicalId":50667,"journal":{"name":"Colombia Medica","volume":"121 1","pages":"25-30"},"PeriodicalIF":1.1,"publicationDate":"2016-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"79596076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
Tratamiento de la enfermedad linfoproliferativa post-trasplante renal con Rituximab y conversión a inhibidor m-TOR. 用利妥昔单抗治疗肾移植后淋巴增生性疾病并转化为m-TOR抑制剂。
IF 1.1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2016-01-01 DOI: 10.25100/cm.v47i4.1989
J. F. Nieto-Ríos, SM Gómez de los Ríos, L. M. Serna-Higuita, Catalina Ocampo-Kohn, Arbey Aristizábal-Alzate, K. Gálvez-Cárdenas, G. Zuluaga-Valencia
{"title":"Tratamiento de la enfermedad linfoproliferativa post-trasplante renal con Rituximab y conversión a inhibidor m-TOR.","authors":"J. F. Nieto-Ríos, SM Gómez de los Ríos, L. M. Serna-Higuita, Catalina Ocampo-Kohn, Arbey Aristizábal-Alzate, K. Gálvez-Cárdenas, G. Zuluaga-Valencia","doi":"10.25100/cm.v47i4.1989","DOIUrl":"https://doi.org/10.25100/cm.v47i4.1989","url":null,"abstract":"","PeriodicalId":50667,"journal":{"name":"Colombia Medica","volume":"1 1","pages":"196-202"},"PeriodicalIF":1.1,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88312928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Colombia Medica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1